Genomics company explores NFTs in hopes of advancing precision medicine
GeneNFTs may be a game-changer for genomic testing, but user education is still needed in order for this model to advance.
GeneNFTs may be a game-changer for genomic testing, but user education is still needed in order for this model to advance.
Original source
Read on CointelegraphRelated market context
‘I Never Said the Company Could Not Sell Bitcoin’: Saylor Walks Back ‘Never Sell’ at BTC Prague
Strategy founder Michael Saylor told the BTC Prague conference he “never said the company could not sell bitcoin,” clarifying the...
SpaceX’s Record $75 Billion IPO and Iran Deal Hopes Reshape Global Markets: What It Means for Crypto
SpaceX's record $75 billion IPO and Iran deal hopes reshape markets. Explore implications for Bitcoin, crypto sentiment, and what...
SpaceX IPO set for tomorrow, testing tokenized equity products
The SpaceX IPO could revolutionize future public offerings by validating tokenized equity, potentially reshaping retail investor a...
Trump declares Iran conflict settled as Bitcoin rallies on peace hopes
The Iran conflict's resolution may stabilize oil prices, reduce inflation fears, and impact crypto markets, especially those linke...
Citi Launches Crypto Platform to Tokenize Private Company Shares
Just in, Citi(Citigroup) is launching a crypto platform to tokenize and trade shares of late-stage private companies for instituti...
Citi Rolls Out Tokenized Private-Company Shares for Wealth and Institutional Clients
Citigroup is rolling out tokenized shares of private companies for its wealth-management and institutional clients, the Wall Stree...